🇺🇸

US SEC Filing Intelligence

· daily

USA Insider Trading Pulse — October 28, 2026

The USA Insider Trading Pulse for 2026-10-28 covers 50 SEC Form 4 filings, overwhelmingly consisting of insider sales, purchases, equity awards, tax withholdings and gifts rather than M&A or financial-statement events. Insider sentiment is mixed-to-negative in aggregate: roughly 20 filings are sales (dominated by a cluster of DRDGOLD LTD officers selling at a uniform $2.44 price after exercising conditional share awards, and sales by Roper, Travelers, State Street, Veracyte and Fifth Third insiders), while open-market purchases are concentrated in a handful of names including Accenture's Chair/CEO, Flagstar, XBiotech, Huntington preferred and Beacon Financial. The most material signal is Accenture's CEO Sweet Julie Spellman buying roughly $3.0M of Class A shares across two transactions at ~$245-246, which is a rare high-conviction open-market buy from a senior executive. Several sales were executed under Rule 10b5-1 plans (Verizon, Sturm Ruger, Castle Biosciences, Veracyte, Beta Bionics, Paylocity, State Street, Agios, Fiverr), which lowers the informational weight of those disposals. Because the filings are single-day Form 4 snapshots, period-over-period financial comparisons, forward guidance and capital allocation data are largely absent; conclusions here rest on transaction patterns, sizes and clustering rather than fundamentals.

50 high priority 50 total filings
· daily

US Merger & Acquisition SEC Filings — October 28, 2026

Across the eight filings for the USA M&A & Takeover Activity stream (all dated 2026-10-28), activity centers on SPAC mechanics and one completed operating-company acquisition. Enerpac Tool Group's $472 million SFE Group purchase is the only true industrial M&A event: it implies 10.6x trailing adjusted EBITDA (9.5x with synergies) and lifts pro forma net debt-to-adjusted EBITDA to roughly 2.3x, making it the most material item in the set. The remaining seven filings are blank-check or SPAC-related and show a common pattern of sponsor-funded extensions, related-party payments outside trust accounts, Nasdaq compliance deficiencies, and auditor changes. Period-over-period comparisons are largely unavailable because most filers are pre-combination shells, so trend analysis is limited to the operating target SFE Group and the Elroy Air deal's pipeline disclosures. The dominant market implication is that SPAC sponsors are increasingly financing deadline extensions and insider compensation with sponsor capital, raising dilution and governance questions for public holders. Scope note: SPAC-only filings are retained because they fall squarely within the Merger/Acquisition and takeover focus.

8 high priority 8 total filings
· monthly

US Pre-Market SEC Filings Roundup — October 28, 2026

Across the 50 overnight US SEC filings (Oct 27-28, 2026), the dominant themes are insider Form 4 activity dominated by tax-withholding on equity vesting (WD-40, Alphabet, Symbotic), and a cluster of foreign private issuer 6-K filings that mostly furnish press releases not included in the text. The most material substantive developments are SK hynix's shareholder-return framework (~Won 100 trillion FY2026 target with a Won 20 trillion treasury share buyback), NOMURA's strong first-half growth (net revenue +24.6% YoY) with costs rising faster (+26.0%), Biogen's mixed Q3 (revenue +11% YoY but non-GAAP EPS down 46% on acquired IPR&D and net debt of ~$6.4B), and Avantor's return to organic growth (+5.2%) against elevated GAAP net leverage of 9.6x. Corporate-action and M&A activity is concentrated in LCI Industries (Monomoy unsolicited non-binding proposal layered on the pending Patrick Industries merger) and Elroy Air's SPAC path with Inflection Point VII. Consumer and industrial names show a shared softness in China and Vans, with Otis New Equipment China sales down over 20% and VF's Vans down 9.8% YoY, offset by better-than-guided profitability. Several financial institutions disclosed capital and governance updates (Santander's P2R falling to 1.65%, KB Financial's CEO succession nominee), and the overall tone is selectively constructive with execution risk concentrated in high-leverage and China-exposed names.

14 high priority 36 medium 50 total filings
· daily

S&P 500 Technology Sector SEC Filings — October 27, 2026

Across the nine filings, the dominant theme is heavy capital and contingent commitment in AI infrastructure and cyber/software consolidation, with the most material item being Broadcom's roughly $43 billion maximum potential backstop liability tied to custom AI racks and customer leases, which the company characterizes as low probability. Palo Alto Networks shows strong fiscal 2026 growth (total revenue $11.48 billion, up 24% YoY; NGS ARR $9.10 billion, up 63% YoY; RPO $21.2 billion, up 34% YoY) while absorbing a partial year of its largest acquisition, CyberArk (rebranded Idira), and adding nearly $1 billion of net new NGS ARR in Q4 alone. Insider activity at Oracle is uniformly routine: several officers and directors had shares withheld for taxes at $125.54 and received RSU/option conversions, with no open-market selling evident in the provided text. CrowdStrike's CEO sold shares under a Rule 10b5-1 plan at prices between roughly $236 and $262, a pre-arranged pattern rather than a signal of conviction change. The Analog Devices Schedule 13G/A from BlackRock (8.9% stake as of September 30, 2026) is a passive disclosure with no stated period-over-period change. Enriched period-over-period data is limited for several filings, so breadth conclusions should be treated as tentative.

7 high priority 2 medium 9 total filings
· daily

Nasdaq 100 Stocks SEC Filings — October 27, 2026

Across the ten NASDAQ-100 filings dated 2026-10-27, the dominant themes are earnings-quality divergence at PayPal, a large contingent liability disclosed by Broadcom tied to AI infrastructure financing, and routine insider and institutional ownership activity at Costco, Netflix, Tesla and Analog Devices. PayPal's Q3 2026 headline growth (net revenues +2.0% YoY to $8,584M, non-GAAP EPS +8% to $1.45, TPV +6% to $487.1B, full-year non-GAAP EPS guidance raised to ~$5.60) is undercut by GAAP operating income down 7.8% to $1,402M, GAAP operating margin down 173 bps to 16.3%, net income down 14.0%, and restructuring charges rising to $255M from $69M, with FY'26 GAAP EPS implying a mid-single-digit decline. Nine-month net revenue grew 4.6% but nine-month net income fell 13.3%, and short-term debt rose to $2,533M from $1,596M while cash declined to $7,160M from $8,049M at year-end 2025. Broadcom's Item 2.03 disclosure of a backstop for a special purpose vehicle carrying custom AI racks, with maximum undiscounted exposure of roughly $43B, is the most material development in the set and represents a significant off-balance-sheet commitment that investors should scrutinize. Costco's executive withholding activity (Sullivan, Polit, Self) reflects routine equity vesting rather than discretionary selling, and Netflix director Bradford Smith's 10b5-1 sales (~$761K at $63.55) appear plan-driven. Amgen's board addition of David Gibbs adds consumer and digital-transformation expertise with no financial content. Overall the set skews toward caution on balance-sheet and earnings-quality questions while signalling continued institutional accumulation in large-cap technology and semiconductor names.

7 high priority 3 medium 10 total filings
· daily

US Activist Hedge Fund Institutional SEC 13D 13G — October 27, 2026

The 50-filing batch is dominated by passive Schedule 13G and 13G/A disclosures from BlackRock, First Trust, and affiliated institutional filers, nearly all tagged neutral and materiality 2-4/10, reporting ownership positions as of 09/30/2026 and filed 10/27/2026. The enriched fields in this batch are sparse: no period-over-period financial comparisons, forward guidance, insider transaction logs, or capital allocation data are present in the filing summaries, so quantitative trend analysis across companies is not supported by the data provided. The materially relevant developments are concentrated in a handful of 13D/A amendments involving genuine control or conviction signals: Dogwood Therapeutics (Sealbond rising to ~75.2% after a $5.0M private placement at $1.22/share), AI OKTO Corp. (Pani Corp. at ~77.2% after a spin-off distribution plus open-market buying of 130,000 shares), Pluri Inc. (CHLP crossing the 35% blocker at ~38.85%), CDT Equity (Corvus/Manoira/Regan at 22.1% after equity-settled fees and severance amid two reverse splits), and Red Robin (JCP/Jumana exiting board-level cooperation rights after director resignations). Concentration of ownership in micro-cap or thinly traded names (ETF shares, Dogwood, AI OKTO, CDT Equity) is the most notable portfolio-level pattern, while large-cap 13G filings from BlackRock are routine. Because most filings are administrative, the actionable intelligence is limited to a few control-consolidation and governance-exit events.

6 high priority 44 medium 50 total filings
· daily

S&P 500 Financials Sector SEC Filings — October 27, 2026

Across the 15 filings in the USA S&P 500 Financials stream, the dominant theme is a split between strong top-line growth and weaker quality of earnings: S&P Global (revenue +7% YoY, but GAAP EPS flattered by a one-time Energy disposition gain and GAAP EPS guidance cut to $16.25-$16.50), Visa (net revenue +13% in Q4 and +15% for FY2026 to a record $45.9B, but GAAP opex growth of only 7% vs 12% non-GAAP and international transaction revenue up just 8%), and Robinhood (record $1.42B revenue, +12% YoY, yet net income -14% and crypto revenue -55% on a 38% drop in crypto notional volume). Insider activity at Goldman Sachs dominates the filing count: at least five Form 4s show routine tax-withholding on vesting RSUs/PSUs at $891.30, with CEO David Solomon and President John Waldron the largest withholding events, while the only open-market sale by a Goldman officer is Solomon's ~9,181-share sale at $910.46; Northern Trust's General Counsel sold ~$2.86M, and CME's CIO sold ~$1.49M, which read as modest-conviction selling rather than a signal. Corporate financing and fund-restructuring disclosures (Marsh & McLennan's €1.2B notes, the Morgan Stanley/Eaton Vance municipal ETF conversions) are operationally routine with limited near-term valuation impact. Overall the stream points to healthy franchise demand with a clear need to look through GAAP one-offs and cost-growth disclosures before extrapolating earnings.

11 high priority 4 medium 15 total filings
· daily

S&P 500 Energy Sector SEC Filings — October 27, 2026

Across the seven filings for the S&P 500 Energy stream dated 2026-10-27, the picture is mixed: operating fundamentals at midstream and integrated names (ONEOK, Expand Energy, Baker Hughes) show top-line growth, but earnings quality and cash generation weakened in the quarter. Expand Energy's Q3 2026 GAAP net income fell about 5% YoY to $519M ($2.24 diluted EPS vs $2.28), while its nine-month income rose sharply, aided by $784M of derivative gains versus $314M a year earlier; the marketing segment drove revenue growth (marketing revenue $927M vs $666M) while natural gas, oil and NGL revenue was nearly flat (+1.7%). Baker Hughes showed 14% YoY revenue growth ($8,025M) largely from the Chart Industries acquisition, yet GAAP net income fell 33% YoY to $411M and adjusted net income grew only about 2%, with operating and free cash flow declining sequentially. ONEOK reported net income of $1.35B ($2.13/diluted share) with adjusted EBITDA up 6% YoY to $2.24B and raised 2026 guidance (adjusted EBITDA midpoint $8.55B), though part of the strength reflects a one-time $336M noncash tax benefit and several segments declined. Capital returns were material at Expand Energy, which repurchased roughly $900M of stock year-to-date, while cash fell to $118M from $616M at year-end. The remaining two items are routine BlackRock 13G/13G-A ownership filings (Exxon and Marathon Petroleum, plus an ExxonMobil Holdings 13G) with no change-of-control intent, carrying low materiality. Overall, the sector theme is reported earnings resilience masking weaker underlying cost trends and cash conversion.

1 high priority 6 medium 7 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — October 27, 2026

The Consumer Staples stream for 2026-10-27 contains 7 filings, of which 5 are in scope: Coca-Cola's Q3 2026 8-K, four Costco and Hormel Form 4 insider filings, and a BlackRock 13G/A on Clorox. Coca-Cola is the only filing with substantive operating and period-over-period data: net revenues up 7% to $13.4B, organic revenue up 7%, unit case volume up 5%, operating margin expanded to 33.4% from 32.0%, and comparable EPS up 11% to $0.91 with full-year guidance raised to at least 11% growth. Underneath the headline strength, volume quality is uneven, with North America unit case volume flat, EMEA losing value share, Asia Pacific price/mix down 2%, and sports drinks volume down 3% globally. The Costco and Hormel filings are routine tax-withholding transactions on equity awards at Costco (~$1,018 per share) and Hormel (~$21-25 per share) and carry low informational value, though they show no open-market selling by executives. The Clorox 13G/A reports BlackRock at 6.3% ownership as a passive, ordinary-course holder with no control intent. Overall the stream's signal is concentrated in one company, with insider activity reading as neutral and compensation-driven rather than conviction-driven.

5 high priority 2 medium 7 total filings
· daily

S&P 500 Industrials Sector SEC Filings — October 27, 2026

Across the 13 in-scope S&P 500 Industrials filings, the dominant theme is a split between strong top-line momentum and margin or cash-flow pressure. UPS, Johnson Controls, Boeing, Waste Management and Illinois Tool Works all reported revenue growth, yet each carried a margin or segment-level weakness: UPS took a $279M charge including a $182M Supply Chain Solutions goodwill impairment, Waste Management saw adjusted EBITDA margin slip 10 bps to 31.0% on fuel and risk-management costs, and ITW's Automotive OEM margin fell 170 bps to 20.1%. Boeing shows the clearest period-over-period repair, with nine-month net loss narrowing to $551M from $5,982M and Q3 operating earnings of $354M versus a $4.8B loss, but nine-month free cash flow remains negative at ($359)M and Commercial Airplanes still posted a $697M operating loss. Johnson Controls is the clear growth outlier, with Americas organic orders up 58% and backlog up 43% organically to $23.0B on data center demand, and it initiated FY27 guidance of 11-12% organic growth. Insider activity is concentrated at Honeywell (CEO and General Counsel sales of roughly $1.4M and $0.65M) and Lockheed Martin (COO sale and director gift), while Caterpillar's executive filings are routine phantom-stock grants. Capital allocation is a watch point at ITW, where Q3 buybacks of $187M sit well below the ~$1.5B full-year pace, implying a heavier Q4 repurchase cadence. Overall the portfolio reads as a cyclical recovery with uneven execution: aerospace and data-center-linked names are inflecting, while waste, auto-linked and transport segments are absorbing cost pressure.

6 high priority 8 medium 14 total filings
· daily

US Material Events SEC 8-K Filings — October 27, 2026

Across 50 SEC 8-K filings dated 2026-10-27, the dominant theme is governance and leadership churn, with a cluster of CEO, CFO, CAO and director departures (Cooper Companies, Visteon, Goodyear, Air Lease, Mid Penn, Ares funds, Allegiant, Hycroft) and several M&A and capital-markets transactions (Ares/MFIC, Vertiv/UIG, Guidewire/hyperexponential, Alamo/Econ, ATII/Forge Nano, Xylem divestiture plan). Period-over-period results are mixed: CoStar (revenue +14% YoY, Adj. EBITDA roughly doubled), Slide Insurance (net income +24.5% YoY) and Manhattan Associates (Cloud +28%) show strong growth, while Xylem (reported revenue -3%, guidance cut), Manhattan's operating cash flow (-26% YoY) and Slide's combined ratio deterioration (48.5% to 59.3%) flag quality-of-earnings concerns. Several mixed-sentiment deals carry valuation or structural questions: MFIC's preliminary NAV of $12.86 sits above the $10.88 ARCC offer, and SecureTech and Ecominas rely on non-cash, contingent or preferred-stock consideration. Near-term catalysts cluster in November and December 2026 (MFIC NAV on Nov 5, Guidewire guidance in December, Rouquet's Goodyear start Dec 1, CooperCompanies CEO search), making the coming weeks a high-information period.

50 high priority 50 total filings
· daily

Insider Trading Pulse — October 27, 2026

Across 50 same-day SEC Form 4 filings (2026-10-27), insider activity is dominated by routine compensation events rather than discretionary open-market conviction. Of the filings, roughly 13 are genuine open-market purchases (Pluri, Agora, Ategrity, Fundrise, First Financial Bankshares, KKR Income Opportunities, Consumers Bancorp, Northpointe Bancshares, and a few smaller items), while sales are concentrated in a handful of 10b5-1-style or director disposals (Sea Ltd, EuroDry, EUROSEAS, Euroholdings, Becton Dickinson, Energy Evolution, Saba Capital). The most material discretionary signals are Northpointe Bancshares' chairman/CEO buying roughly $1.5M across two lots near $15.3-15.4, and Pluri's director buying 833,334 shares at $1.50 (~$1.25M) alongside warrants. Withholding-for-tax events at Ingram Micro (all at $27.50), JAKKS Pacific, Frontier Group and Silver Bow reflect vesting and option exercises rather than views on price. Period-over-period comparisons are not supplied in the enriched payloads for these filings, so trend claims are limited to what the transactions themselves show. Director equity grants cluster heavily at Park National (13 identical 301-share awards) and Toyota (multiple small awards at $19.87), which signal routine board compensation rather than sentiment.

50 high priority 50 total filings
· daily

Dow Jones 30 Stocks SEC Filings — October 27, 2026

Across the 17 Dow Jones 30 filings dated 2026-10-27, the dominant theme is a split between strong top-line growth and pressure on margins and cash flow. Coca-Cola (net revenue +7%, comparable EPS +11%, FY guide raised to at least 11%) and Visa (FY net revenue a record $45.9B, +15%; Q4 GAAP EPS +18%) show healthy fundamentals, though Visa's non-GAAP opex (+16% FY) outpaced GAAP opex (+11%), and its international transaction revenue grew only 8%. Sherwin-Williams (Q3 sales +7.9%, but diluted EPS +0.9%, FY adjusted EPS guide narrowed to $11.85-$12.15 and GAAP guide cut to $10.92-$11.22) and Boeing (Q3 revenue +4% YoY, Commercial Airplanes revenue -3%, nine-month free cash flow -$359M) illustrate how cost inflation and program charges are eroding earnings quality. Insider flow is heavily skewed toward Goldman Sachs and Honeywell, where the largest disclosed sales (CEO Solomon ~$8.4M, Honeywell CEO Kapur ~$1.43M) came alongside large tax-withholding events on vesting awards, so the signal is mostly compensation mechanics rather than conviction. Net, the set argues for selectivity: quality compounders with pricing power and visible guidance (Coca-Cola, Visa) versus names where margin repair and cash conversion are still unproven (Boeing, Sherwin-Williams).

13 high priority 4 medium 17 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — October 27, 2026

Four of the five filings (Rekor Systems, Advasa Holdings, NextNRG, Socket Mobile) are Nasdaq listing-compliance events tied to sub-$1.00 bid prices or stockholders' equity and market value shortfalls, forming a clear cluster of small-cap distress on Nasdaq. NextNRG is the most acute case: it fails bid price, MVLS, and stockholders' equity tests, was ineligible for a second compliance period, and awaits a Hearings Panel decision with no assurance of continued listing. Socket Mobile is voluntarily migrating to the OTCID Market (last Nasdaq day expected November 18, 2026), a move that typically reduces liquidity and institutional ownership. Rekor received a 180-day extension to April 26, 2027, and Advasa has until April 19, 2027, both deadlines that fall in the same spring window and could produce a concentrated wave of reverse-split or delisting events. General Motors' 8-K contains only bylaw amendments (effective November 17, 2026) with no financial data, so it is low-materiality for this distress stream. The filings do not disclose period-over-period financials, insider transactions, or capital allocation, so quantitative trend analysis is limited; the intelligence is primarily about listing status and timing.

5 high priority 5 total filings
· daily

Global High-Priority Regulatory Events — October 27, 2026

The 50-filing digest for the Global High Priority Market Events stream (US SEC scope, date 2026-10-27) is dominated by insolvency and corporate-governance disclosures from Indian listed companies, a cluster of Nasdaq continued-listing deficiency notices, ETF delisting notices, and a few material M&A and business-combination events. The most market-moving items are Holcim's tender offer for Cementos Pacasmayo (mixed, materiality 9), the ATII Holdings/Forge Nano reverse recapitalization with a heavily diluted public float (ATII public holders retain only 0.6% of Pubco), Vertiv's $1.45B upfront acquisition of UtilityInnovation Group (positive, accretive to adjusted EPS in year one), and Madison Square Garden Sports' spin-off of MSG Rangers. Period-over-period data is mixed: Manhattan Associates grew Q3 revenue 11% and Cloud subscription revenue 28%, but operating cash flow fell 26% and DSO rose from 67 to 81 days; Tribhovandas Bhimji Zaveri saw gross margin compress from 16.9% to 14.2% and Q2 PAT fall 49.7%; Maral Overseas grew quarterly revenue 14.4% YoY but remained exposed through a loss-making garment segment. Several Indian filings (Premier Limited, Kkalpana Plastick) lack financial figures entirely, and multiple Premier Limited CoC intimations were filed months after the underlying meetings, which is itself a governance flag. Portfolio-level, the theme is distress and governance-driven corporate action rather than broad earnings momentum.

50 high priority 50 total filings
· daily

US SEC Filings Daily Market Digest — October 27, 2026

Across 50 SEC filings dated October 27, 2026, the dominant themes are a sharp divergence between headline earnings and underlying quality, and a heavy flow of 13F institutional holdings disclosures with limited actionable content. Large-cap operators showed mixed results: UPS beat on adjusted EPS and raised full-year guidance despite a $279M GAAP charge and a tough comparison against a $330M prior-year gain, Centene swung to positive GAAP earnings but its at-risk membership fell from 27.97M to 25.70M, and Rexford Industrial posted a nine-month net loss of $(411.2)M driven by a $703.4M impairment even as it repurchased $609.1M of stock. Banks and financials were similarly bifurcated: Independent Bank's per-share earnings slipped to $0.80 from $0.84 with non-performing loans rising to $39.2M, HSBC USA's Q3 net income fell 18% while trading revenue jumped 49%, and Nomura reported solid capital ratios (CET1 13.20%) without a prior-period comparison. Capital returns were a notable thread, with Arlo authorizing a $100M buyback, Hilton reaffirming roughly $3.5B of 2026 capital return, Equinor continuing its tranche buyback at NOK 435 average in recent days, and HSBC USA cutting common dividends to $300M for nine months from $1,500M. Corporate events of note include the Woodside Greater Sunrise sale to Timor Gap, the David's Bridal/Pearl SPAC combination at a $350M valuation, and Sands China's planned USD senior notes offering, though most filings were procedural and lacked quantitative terms. Overall the tone is cautiously constructive for quality cash generators but warns against extrapolating one-off gains, impairments and timing-driven volume into run-rate performance.

14 high priority 36 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — October 27, 2026

Across the nine filings, the dominant theme is strong top-line momentum at Hilton tempered by slowing forward guidance and rising leverage, with the remaining filings being largely procedural (proxy materials, bylaws, passive ownership disclosures) and offering little quantitative signal. Hilton's Q3 2026 total revenues rose 6.6% YoY to $3,325M and net income attributable to stockholders jumped 27.4% to $536M, yet nine-month operating cash flow fell 6.0% to $1,811M and Ownership revenue contracted 5.6% in the quarter. Management guided Q4 RevPAR to 3.0%-3.5% versus Q3's 5.8%, and cut full-year Adjusted EBITDA guidance, with the Q3 strength partly attributed to non-recurring World Cup and calendar tailwinds. Balance sheet strain is visible: total debt climbed to $13,453M from $12,459M, interest expense rose to $529M year-to-date from $455M, and current maturities jumped to $626M from $25M at year-end 2025. Las Vegas Sands' planned USD note offering at Sands China and GM's bylaw amendments are governance and financing events without disclosed economics, so their market impact cannot yet be sized. The passive ownership filings (BlackRock stakes in Tesla at 4.96%, Hilton at 7.3%, Aptiv at 6.0%) are routine and carry no activist or control signal.

3 high priority 6 medium 9 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — October 27, 2026

Five filings were reviewed for the USA S&P 500 Healthcare stream, with four newly published and one (Baxter 13G/A) included for context. Centene dominates the signal flow: Q3 2026 GAAP net loss of $(71) Million compares with a $(6,631) Million loss in Q3 2025 that carried a $6,723-6,743 Million goodwill impairment, while nine-month GAAP net earnings swung to $2,561 Million from a $(5,573) Million loss and adjusted nine-month EPS rose to $6.45 from $3.26. Guidance was internally mixed: the GAAP EPS floor was raised to greater than $3.46 and the adjusted floor to greater than $5.20, yet the HBR guidance range was lowered to 90.4%-91.1%, and operating cash flow was negative at $(3,669) Million. Underneath the headline recovery, commercial premium revenue fell 21% YoY and at-risk membership declined from 27.97 million to 25.70 million, with Medicare and PDP growth only partly offsetting the losses. Debt reduction is a clear positive, with long-term debt falling to $15,454 Million from $17,351 Million at year-end 2025. The remaining filings are low-materiality governance and routine disclosures: an Amgen board appointment, a small Becton Dickinson 10b5-1 sale by the Chief Revenue Officer, and a BlackRock passive 5.9% stake in Baxter. Portfolio-level read-through is that Managed-care earnings are recovering off a depressed base while top-line and cash conversion remain under pressure.

3 high priority 2 medium 5 total filings
· daily

US Earnings Financial Results SEC Filings — October 27, 2026

Across 50 US SEC quarterly filings for the period ending around late October 2026, results were broadly mixed: nearly every filing carries a 'mixed' sentiment tag, with strong top-line growth frequently offset by margin compression, rising interest expense, tax-rate swings, or one-time gains that flatter headline earnings. Revenue growth was strongest in healthcare services (Ensign +14.5%, Welltower +38.4% driven by acquisitions), industrial distribution (Reliance +42.8%, Knowles +20.3%), and pharma commercialization (Kiniksa +58.1%), while consumer and cyclical names such as Enphase (-28.5%), Herc equipment sales (-43.7% in the quarter), Armstrong Agriculture (-6.4%), and Caesars (operating income -10.9%) show clear deterioration. Balance sheets are being levered up for M&A and shareholder returns: Xylem, Itron, Welltower, INNIO, and Hilton all added material debt, while Rexford, Expand Energy, Royal Caribbean and several banks returned capital aggressively. Working-capital absorption is a recurring cash-flow theme (Reliance receivables +$938.6M, Hycroft and Inventory builds at Kiniksa, Beta Bionics, INNIO and DMC Global). Several headline earnings figures are inflated by non-recurring items (TransUnion's $225.5M acquisition gain, NXP's $627M asset-sale gains, Expand's large YTD swing, Highwoods' $109.6M disposition gains), so underlying growth is materially smaller than reported. Market implication: investors should discount headline EPS growth and focus on operating cash conversion, interest burden, and the sustainability of tax and gain-driven earnings.

50 high priority 50 total filings
· daily

US Executive Compensation Proxy SEC Filings — October 27, 2026

This batch of 23 DEF 14A filings for the 2026-10-27 window is dominated by governance and shareholder-vote mechanics rather than compensation design: most proxies are routine (director elections, auditor ratification, say-on-pay) or capital-structure items (reverse splits, share authorizations, Yorkville financings, blank-check extensions). The most material situations are Mistras Group's $20.35/share cash take-private, Impact Biomedical's reverse-merger with Zoar (pending NYSE Amex listing and a July 1, 2026 outside date), VisionWave's dilution-heavy special meeting with the stock at $3.72 versus Yorkville floor prices, and Palo Alto Networks' strong fiscal 2026 growth ($11.48B revenue, up 24%; NGS ARR $9.10B, up 63%; RPO $21.2B, up 34%) absorbing the CyberArk acquisition. Among filings that disclose period-over-period figures, the picture is mixed: Stride reported net income up more than 17% and Adjusted EBITDA up more than 8%, SES AI showed Q2 revenue up over 40% YoY but down roughly 24% sequentially, and Armlogi's revenue fell 2.4% while its net loss widened 36.6%. Many proxies (Cimpress, KULR, PGIM ETF Trust, Oil-Dri, Fatpipe, Precision Optics, Galaxy Gaming) contain no financial results, so enriched period comparisons and insider-trading data are largely unavailable for them. Governance concerns recur across the set, including concentrated or super-voting control (HWH International at ~94.8% controlled, SES AI Class B shares at 10 votes, KULR Series A at 100 votes per share), combined CEO/Chair roles without a lead director, and auditor transitions (Marcum resignations at La Rosa and KULR, Grassi to HTL at HWH).

23 high priority 23 total filings